Document:

1st Amendment to Loan and Security Agreement

 Exhibit 10.8 
  
 FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT 
 BY AND BETWEEN 
 CONGRESS FINANCIAL CORPORATION (FLORIDA) 
  
 AND 
  
 DRUGMAX, INC., TOGETHER WITH ITS SUBSIDIARIES, 
 VALLEY DRUG COMPANY, VALLEY DRUG COMPANY SOUTH, 
 AND DISCOUNT Rx, INC.

  
 THIS FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT (this
“Amendment”) is entered into effective as of the 19th day of August, 2003, by and between DRUGMAX, INC., a Nevada corporation (“Borrower”), (together with its subsidiaries, VALLEY DRUG COMPANY, an Ohio corporation, VALLEY DRUG
COMPANY SOUTH, a Louisiana corporation, and DISCOUNT Rx, Inc., a Louisiana corporation, also the “Borrower”), and CONGRESS FINANCIAL CORPORATION (FLORIDA), a Florida corporation (“Lender”). 
  
 W I T N E S S E
T H: 
  
 WHEREAS, Borrower and Lender heretofore
entered into that certain Loan and Security Agreement dated April 15, 2003 (the “Loan Agreement”) pursuant to which Lender agreed to make loans and provide other financial accommodations to Borrower; and 
  
 WHEREAS, Borrower has now requested Lender to include the assets acquired
from Avery Pharmaceuticals. Inc. and certain changes be made to the Loan Agreement including changes to the Eligible Accounts, and the EBITDA financial covenant and Lender is willing to agree to such financing and such changes, subject to the terms
and conditions set forth herein. 
  
 NOW, THEREFORE, for and in
consideration of the above premises, the mutual covenants and agreements contained herein and other good and valuable consideration, the receipt whereof is hereby acknowledged, Borrower and Lender agree as follows: 
  
 1. Definitions. All capitalized terms contained herein shall have the
meanings assigned to them in the Loan Agreement unless the context herein otherwise dictates or unless different meanings are specifically assigned to such terms herein. 

 2. Particular Amendments to Loan Agreement. The Loan Agreement is hereby amended as follows:

  
 (a) Change to Subsection 1.20. Subsection 1.20 of the
Loan Agreement is hereby amended to read in its entirety as follows: 
  
 1.20 “Eligible Accounts” shall mean Accounts created by Borrower which are and continue to be acceptable to Lender based on the criteria set forth below. In general, Accounts shall be Eligible Accounts if: 
  
 (a) such Accounts arise from the actual and bona fide sale
and delivery of goods by Borrower or rendition of services by Borrower in the ordinary course of its business which transactions are completed in accordance with the terms and provisions contained in any documents related thereto; 
  
 (b) such Accounts are (i) neither unpaid more than thirty (30) days after
the due date, nor more than sixty (60) days after the date of the original invoice for them, provided however, that (ii) notwithstanding subsection (i) hereof the Accounts listed on Schedule 1.20 hereof, each of which shall be subject
to net 30 day terms, shall be considered Eligible Accounts so long as such Accounts are not unpaid more than sixty (60) days after the due date nor more than ninety (90) days after the date of the original invoice for them and otherwise meet the
criteria for Eligible Accounts set forth in this Subsection 1.20; 
  
 (c) such Accounts comply with the terms and conditions contained in Section 7.2(b) of this Agreement; 
  
 (d) such Accounts do not arise from sales on consignment, guaranteed sale, sale and return, sale on approval, or other terms under which payment by the
account debtor may be conditional or contingent; 
  
 (e) the
chief executive office of the account debtor with respect to such Accounts is located in the United States of America, including Puerto Rico, or Canada (provided, that, at any time promptly upon Lender’s request, Borrower shall
execute and deliver, or cause to be executed and delivered, such other agreements, documents and instruments as may be required by Lender to perfect the security interests of Lender in those Accounts of an account debtor with its chief executive
office or principal place of business in Canada in accordance with the applicable laws of the Province of Canada in which such chief executive office or principal place of business is located and take or cause to be taken such other and further
actions as Lender may request to enable Lender as secured party with respect thereto to collect such Accounts under the applicable Federal or Provincial laws of Canada) or, at Lender’s option, if the chief executive office and principal place
of business of the account debtor with respect to such Accounts is 
  

 2 

 located other than in the United States of America, including Puerto Rico, or Canada, then if either:
(i) the account debtor has delivered to Borrower an irrevocable letter of credit issued or confirmed by a bank satisfactory to Lender and payable only in the United States of America and in U.S. dollars, sufficient to cover such Account, in form and
substance satisfactory to Lender and if required by Lender, the original of such letter of credit has been delivered to Lender or Lender’s agent and Borrower has complied with the terms of Section 5.2(f) hereof with respect to the assignment of
the proceeds of such letter of credit to Lender or naming Lender as transferee beneficiary thereunder, as Lender may specify, or (ii) such Account is subject to credit insurance payable to Lender issued by an insurer and on terms and in an amount
acceptable to Lender, or (iii) such Account is otherwise acceptable in all respects to Lender (subject to such lending formula with respect thereto as Lender may determine); 
  
 (f) such Accounts do not consist of progress billings (such that the obligation of the account debtors with respect to such
Accounts is conditioned upon Borrower’s satisfactory completion of any further performance under the agreement giving rise thereto), bill and hold invoices or retainage invoices, except as to bill and hold invoices, if Lender shall have
received an agreement in writing from the account debtor, in form and substance satisfactory to Lender, confirming the unconditional obligation of the account debtor to take the goods related thereto and pay such invoice; 
  
 (g) the account debtor with respect to such Accounts has not asserted a
counterclaim, defense or dispute and Borrower does not owe any amounts to the account debtor with respect to such Accounts, and such account debtor does not claim that Borrower owes any amounts to such account debtor, that may give rise to any right
of setoff or recoupment against such Accounts (but the portion of the Accounts of such account debtor in excess of the amount at any time and from time to time owed by Borrower to such account debtor or claimed owed by such account debtor may be
deemed Eligible Accounts); 
  
 (h) there are no facts, events or
occurrences which would impair the validity, enforceability or collectability of such Accounts or reduce the amount payable or delay payment thereunder; 
  

 3 

 (i) such Accounts are subject to the first priority, valid and perfected security interest of Lender and
any goods giving rise thereto are not, and were not at the time of the sale thereof, subject to any security interests or liens except those permitted in this Agreement that are subject to an intercreditor agreement in form and substance
satisfactory to Lender between the holder of such security interest or lien and Lender; 
  
 (j) neither the account debtor nor any officer or employee of the account debtor with respect to such Accounts is an officer, employee, agent or other Affiliate of Borrower provided, however, that notwithstanding the
foregoing, up to $500,000 in accounts receivable from T&L, Inc. d/b/a Advanced Pharmacy Solutions, a Florida corporation, to Valley Drug Company South and/or Valley Drug Company shall be considered Eligible Accounts hereunder for the period up
to thirty (30) days from the original invoice date for such Accounts, such Accounts are subject to a first perfected security interest in the assets of the Affiliate by the Borrower with a collateral assignment to the Lender and such Accounts meet
all other applicable requirements under this Agreement; 
  
 (k)
the account debtors with respect to such Accounts are not any foreign government, the United States of America, any State, political subdivision, department, agency or instrumentality thereof, unless, if the account debtor is the United States of
America, any State, political subdivision, department, agency or instrumentality thereof, upon Lender’s request, the Federal Assignment of Claims Act of 1940, as amended or any similar State or local law, if applicable, has been complied with
in a manner satisfactory to Lender; 
  
 (l) there are no
proceedings or actions which are threatened or pending against the account debtors with respect to such Accounts which might result in any material adverse change in any such account debtor’s financial condition (including, without limitation,
any bankruptcy, dissolution, liquidation, reorganization or similar proceeding); 
  
 (m) such Accounts of a single account debtor or its affiliates do not constitute more than fifteen (15%) percent of all otherwise Eligible Accounts (but the portion of the Accounts not in excess of such percentage may
be deemed Eligible Accounts); 
  
 (n) such Accounts are (i) not
owed by an account debtor who has Accounts unpaid more than thirty (30) days after the due 
  

 4 

 date, nor more than sixty (60) days after the original invoice date for them, provided
however, that (ii) notwithstanding subsection (i) hereof the Accounts listed on Schedule 1.20 hereof, each of which shall be subject to net 30 day terms, shall be considered Eligible Accounts so long as such Accounts are not unpaid more than
sixty (60) days after the due date nor more than ninety (90) days after the date of the original invoice for them and otherwise meet the criteria for Eligible Accounts set forth in this Subsection 1.20, and in either case such Accounts constitute
more than fifty percent (50%) of the total Accounts of such account debtor provided such percentage shall decrease by five percent (5%) per month beginning the month after the date of closing until the level of twenty-five percent (25%) of
the total Accounts of such account debtor is reached at which time no further decreases shall occur; 
  
 (o) the account debtor is not located in a state requiring the filing of a Notice of Business Activities Report or similar report in order to permit
Borrower to seek judicial enforcement in such State of payment of such Account, unless Borrower has qualified to do business in such state or has filed a Notice of Business Activities Report or equivalent report for the then current year or such
failure to file and inability to seek judicial enforcement is capable of being remedied without any material delay or material cost; 
  
 (p) such Accounts are owed by account debtors whose total indebtedness to Borrower does not exceed the credit limit with respect to such account debtors
as determined by Borrower from time to time in the ordinary course of business consistent with its current practices as of the date hereof and as is reasonably acceptable to Lender (but the portion of the Accounts not in excess of such credit limit
may be deemed Eligible Accounts); and 
  
 (q) such Accounts are
owed by account debtors deemed creditworthy at all times by Lender in good faith. 
  
 The criteria for Eligible Accounts set forth above may only be changed and any new criteria for Eligible Accounts may only be established by Lender in good faith based on either: (i) an event, condition or other
circumstance arising after the date hereof, or (ii) an event, condition or other circumstance existing on the date hereof to the extent Lender has no written notice thereof from Borrower prior to the date hereof, in either case under clause (i) or
(ii) which adversely affects or could reasonably be expected to adversely affect the Accounts in the good faith determination of Lender. Any Accounts which are not Eligible Accounts shall nevertheless be part of the Collateral. 
  

 5 

 (b) Change to Subsection 9.18. Subsection 9.18 of the Loan Agreement is hereby amended to read in
its entirety as follows: 
  
 9.18 EBITDA. Borrower shall
not, for any period set forth below (each a “Test Period”), permit its cumulative EBITDA to be less than the amount set forth opposite such Test Period: 
  

				
	 Test Period

	  	EBITDA

	 4/1/03 – 6/30/03
	  	$	338,000
	 4/1/03 – 9/30/03
	  	$	698,000
	 4/1/03 – 12/31/03
	  	$	1,205,000
	 4/1/03 – 3/31/04
	  	$	1,931,000
	 7/1/03 – 6/30/04
	  	$	2,386,000
	 10/1/03 – 9/30/04
	  	$	2,762,000
	 1/1/04 – 12/31/04
	  	$	2,762,000
	 4/1/04– 3/31/05
	  	$	2,762,000
	 7/1/04 – 6/30/05
	  	$	2,900,000
	 10/1/04 – 9/30/05
	  	$	2,900,000
	 1/1/05 – 12/31/05
	  	$	2,900,000
	 4/1/05 – 3/31/06
	  	$	2,900,000

  
 3. Validity of
Documents. The Financing Agreements as hereby amended are valid, in full force and of full legal effect, and are enforceable in accordance with their terms. There are no known defenses, counterclaims, offsets, demands or claims that Borrower has
in connection with any of the Loans or any of the Financing Agreements that in either such case could be asserted to reduce or eliminate all or any part of Borrower’s obligations under the Financing Agreements or that could be asserted to
mitigate or excuse Borrower’s defaults in payment or performance of the Obligations. 
  
 4. Ratification. Borrower and Lender confirm, ratify and approve all of the terms, covenants and conditions as are expressly amended in this Amendment. Borrower further restates, ratifies and confirms as
accurate all its respective warranties and representations set forth in the Loan Agreement. 
  
 6. No Novation. Except as modified or amended herein, no other term, covenant or condition of the Loan Agreement shall be considered modified or amended, and this Amendment shall not be considered a novation.
 
  
 IN WITNESS WHEREOF, Lender and Borrower have caused
these presents to be duly executed as of the day and year first written above. 
  

 6 

			
	BORROWER
	
	 DRUGMAX, INC.

		
	By:	 	 /s/ Ronald J. Patrick

	Name:	 	Ronald J. Patrick
	Title:	 	VP of Finance
	
	VALLEY DRUG COMPANY
		
	By:	 	 /s/ Ronald J. Patrick

	Name:	 	Ronald J. Patrick
	Title:	 	VP of Finance
	
	VALLEY DRUG COMPANY SOUTH
		
	By:	 	 /s/ Ronald J. Patrick

	Name:	 	Ronald J. Patrick
	Title:	 	VP of Finance
	
	DISCOUNT Rx, INC.
		
	By:	 	 /s/ Ronald J. Patrick

	Name:	 	Ronald J. Patrick
	Title:	 	VP of Finance

  

 7 

			
	LENDER
	
	 CONGRESS FINANCIAL CORPORATION
 (FLORIDA)

		
	By:	 	 /s/ Pat Cloninger

	Name:	 	Pat Cloninger
	Title:	 	Vice President

  

 8Second Amendment to Loan and Security Agreement

 EXHIBIT 10.9 
  
 SECOND AMENDMENT TO LOAN AND SECURITY AGREEMENT 
 BY AND BETWEEN 
 CONGRESS FINANCIAL CORPORATION (FLORIDA) 
  
 AND 
  
 DRUGMAX, INC., TOGETHER WITH ITS SUBSIDIARIES, 
 VALLEY DRUG COMPANY, VALLEY DRUG COMPANY SOUTH, 
 AND DISCOUNT Rx, INC. 
  
         THIS SECOND AMENDMENT TO LOAN AND SECURITY
AGREEMENT (this “Amendment”) is entered into effective as of the 31st day of March, 2004 (the
“Effective Date”), by and among DRUGMAX, INC., a Nevada corporation (“Borrower”), (together with its subsidiaries, VALLEY DRUG COMPANY, an Ohio corporation, VALLEY DRUG COMPANY SOUTH, a Louisiana corporation, and DISCOUNT Rx,
Inc., a Louisiana corporation, also the “Borrower”), and CONGRESS FINANCIAL CORPORATION (FLORIDA), a Florida corporation (“Lender”). 
  
 W I T N E S S E T H : 
  
         WHEREAS, Borrower and Lender heretofore entered into that certain Loan and Security
Agreement dated effective April 15, 2003 (the “Loan Agreement”) pursuant to which Lender agreed to make loans and provide other financial accommodations to Borrower; and 
  
         WHEREAS, Borrower and Lender entered into that certain First Amendment to Loan and Security
Agreement dated effective August 19, 2003 (“First Amendment”) pursuant to which certain changes were made to the Loan Agreement including changes to the EBITDA financial covenant; and 
  
         WHEREAS, Borrower and Lender have now agreed
that certain additional changes be made to the Loan Agreement including changes to the EBITDA financial covenant, addition of a limitation on capital expenditures, a minimum availability covenant and a modification to Eligible Accounts and Lender is
willing to agree to such changes, subject to the terms and conditions set forth herein. 
  
         NOW, THEREFORE, for and in consideration of the above premises, the mutual covenants and agreements contained herein and other good and valuable consideration, the receipt whereof is hereby
acknowledged, Borrower and Lender agree as follows: 
  
         1. Definitions. All capitalized terms contained herein shall have the meanings assigned to them in the Loan Agreement unless the context herein 

 otherwise dictates or unless different meanings are specifically assigned to such terms herein. 
  
         2. Particular Amendments to Loan
Agreement. The Loan Agreement is hereby amended as follows: 
  
                         (a) Change to Subsection 1.19. Subsection 1.19 of the Loan Agreement is hereby amended to
read in its entirety as follows: 
  
 1.19
“EBITDA” shall mean Borrower’s net income (loss) on a consolidated basis for any accounting period (excluding to the extent included therein any extraordinary and/or one time or unusual and non-recurring gains or any non-cash losses),
after deducting all charges which should be deducted before arriving at the net income (loss) for such period, plus (i) the amount of the provision for federal, state and local income tax for such period, plus (ii) the amount of interest expense
during such period for indebtedness for borrowed money, plus (iii) the amount of the provision for depreciation and amortization for such period determined in accordance with GAAP and, in the case of amounts described in clauses (i), (ii) and (iii),
only to the extent deducted in determining net income for such period. 
  
                         (b) Change to Subsection 1.20(b). Subsection 1.20(b) of the Loan Agreement is hereby
amended to read in its entirety as follows: 
  
 (b) such
Accounts are (i) neither unpaid more than thirty (30) days after the due date, nor more than sixty (60) days after the date of the original invoice for them, provided however, that (ii) notwithstanding subsection (i) hereof (A) the
Accounts as specifically identified by Borrower as subject to net 30 day terms, shall be considered Eligible Accounts so long as such Accounts are not unpaid more than sixty (60) days after the due date nor more than ninety (90) days after the date
of the original invoice for them and otherwise meet the criteria for Eligible Accounts set forth in this Subsection 1.20, and (B) as specifically approved on a case by case basis by the Lender in the Lender’s sole discretion, the Accounts
subject to extended dating terms beyond 30 days but not to exceed thirteen (13) months if in existence on the date hereof, or not to exceed nine (9) months if created hereafter, shall be considered Eligible Accounts so long as such Account is not
unpaid for more than thirty (30) days after the due date of the original invoice and which in the aggregate do not exceed $1,000,000 at any time; provided Borrower specifically request approval for each such Account in writing, in form and
substance satisfactory to Lender, including the specific terms, the reason for the extended terms (such as an initial stocking order to a new customer or a new store opening of an existing customer) and provides appropriate credit history

  

 2 

 and/or financial information on the Account as may be requested by the Lender. 
  
                         (c) Change to Subsection 9.18. Subsection 9.18 of the Loan Agreement is hereby amended to
read in its entirety as follows: 
  
 9.18
EBITDA. Borrower shall not, for any period set forth below (each a “Test Period”), permit its cumulative EBITDA to be less than the amount set forth opposite such Test Period: 
  

			
	 Test Period
	  	EBITDA
		
	 4/1/03 – 3/31/04
	  	$1,650,000
	 7/1/03 – 6/30/04
	  	$1,250,000
	 10/1/03 – 9/30/04
	  	$1,400,000
	 1/1/04 – 12/31/04
	  	$1,550,000
	 4/1/03 – 3/31/05
	  	$1,800,000
	 7/1/04 – 6/30/05
	  	$1,800,000
	 10/1/04 – 9/30/05
	  	$1,800,000
	 1/1/05 – 12/31/05
	  	$2,000,000
	 4/1/04 – 3/31/06 and thereafter
	  	$2,000,000

  
                         (d) New Subsection 9.23. A new subsection 9.23 shall be added to the Loan Agreement to
read in its entirety as follows: 
  
 9.23
Minimum Excess Availability. Borrower shall maintain minimum Excess Availability in the amount set forth below at all times during the period indicated: 
  

			
	 Amount
	  	Period
		
	 (i) $100,000
	  	from May 1, 2004 to and including
May 7, 2004
	 	  	 
	 (ii) $200,000
	  	from May 8, 2004 to and including
May 14, 2004
	 	  	 
	 (iii) $300,000
	  	from May 15, 2004 to and including
May 21, 2004
	 	  	 
	 (iv) $400,000
	  	from May 22, 2004 to and including
May 28, 2004
	 	  	 
	 (v) $500,000
	  	from May 29, 2004 to and including
September 30, 2004
	 	  	 
	 (vi) $700,000
	  	from October 1, 2004 to and including December 31, 2004
	 	  	 
	 (vii) $900,000
	  	from January 1, 2005 to and including March 31, 2005
	 	  	 
	 (viii) $1,000,000
	  	from April 1, 2005 to and including April 15, 2006

  

 3 

                         (e) New Subsection 9.24. A new subsection 9.24 shall be added to the Loan Agreement to
read in its entirety as follows: 
  
 9.24
Limitation on Capital Expenditures. Borrower shall not incur expenditures for fixed or capital assets or improvements, or for replacements, substitutions or additions thereto, which have a useful life of more than one (1) year, including but
not limited to, the direct or indirect acquisition of such assets and obligations under capital leases incurred in respect of such fixed or capital assets during such period which exceed $400,000 in the aggregate, in any fiscal year, beginning on or
after April 1, 2004, during the term of this Agreement. 
  

	        3.	 	Amendment Fee. Borrower shall pay to Lender as an amendment fee the amount of $25,000, which shall be payable upon execution of this Amendment by the Borrower.

  

	        4.	 	Validity of Documents. The Financing Agreements as hereby amended are valid, in full force and of full legal effect, and are enforceable in accordance with their terms. There
are no known defenses, counterclaims, offsets, demands or claims that Borrower has in connection with any of the Loans or any of the Financing Agreements that in either such case could be asserted to reduce or eliminate all or any part of
Borrower’s obligations under the Financing Agreements or that could be asserted to mitigate or excuse Borrower’s defaults in payment or performance of the Obligations. 

  
         4. Ratification. Borrower and Lender
confirm, ratify and approve all of the terms, covenants and conditions as are expressly amended in this Amendment. Borrower further restates, ratifies and confirms as accurate all its respective warranties and representations set forth in the Loan
Agreement, as amended by the First Amendment. 
  
         6. No Novation. Except as modified or amended herein, no other term, covenant or condition of the Loan Agreement, as amended by the First Amendment, shall be considered modified or
amended, and this Amendment shall not be considered a novation. 
  

 4 

 IN WITNESS WHEREOF, Lender and Borrower have caused these presents to be duly executed as of the day and
year first written above. 
  
 BORROWER

  
 DRUGMAX, INC. 
  
 By: /s/ Jugal K.
Taneja                 
 Name:
Jugal K. Taneja                 
 Title: Chairman & CEO               
  
 VALLEY DRUG COMPANY 
  
 By: /s/ Ronald J. Patrick                

 Name: Ronald J.
Patrick                 
 Title:
CFO                                      

  
 VALLEY DRUG COMPANY SOUTH 
  
 By: /s/ William
LaGamba                 
 Name:
William LaGamba                 
 Title:
CEO                                       
  
  
 DISCOUNT Rx, INC. 
  
 By: /s/ William
LaGamba                 
 Name:
William LaGamba                 
 Title:
CEO                                       
  
  
 LENDER 
  
 CONGRESS FINANCIAL CORPORATION 
 (FLORIDA) 
  
 By: /s/ Pat
Cloninger                         
 Name: Pat
Cloninger                         
 Title: Vice
President

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00068-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00068-of-00352.parquet"}]]